Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease

Back

ESC Professional Premium Access

Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease

Session: Metabolic markers in chronic coronary syndrome

Topic: Inflammation and Immunity

Speaker: Doctor M. Polkinghorne (Oxford, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Murray David Polkinghorne

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Gamma-Glutamyl Transferase as a prognostic risk factor in complex coronary disease: a serendipitous (re)discovery of machine learning in the SYNTAXES?

Speaker: Doctor K. Ninomiya (Galway, IE)

Relationship between stress hyperglycemia ratio and long-term poor prognosis in patients with multi-vessel coronary artery disease

Speaker: Doctor M. Li (Nanjing, CN)

Iron deficiency and association with mortality in patients with coronary artery disease

Speaker: Doctor N. Corballis (Norwich, GB)

Impact of transfusion on platelet aggregation and biomarkers in myocardial infarction patients with anemia: an ancillary study of the randomized REALITY trial

Speaker: Professor B. Lattuca (Nimes, FR)

Association between index of microcirculatory resistance and patients' characteristics, coronary computed tomography findings, and the sensor location

Speaker: Doctor M. Hada (Tsuchiura, JP)

Access the full session

Metabolic markers in chronic coronary syndrome

Speakers: Doctor M. Polkinghorne, Doctor K. Ninomiya, Doctor M. Li, Doctor N. Corballis, Professor B. Lattuca...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources